Related Experiment Video
Updated: Jul 18, 2026

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
High glucose promotes the release and expression of novel vasoactive peptide, coupling factor 6, in human umbilical
Xiaolu Li1, Shanshan Xing, Like Zhang
1Shandong University School of Medicine, Ji'nan 250012, China.
Insights
High glucose levels increase plasma coupling factor 6 (CF6) in endothelial cells via protein kinase C (PKC) and p38 MAPK pathways. Insulin treatment counteracted this effect, suggesting a novel mechanism in diabetes mellitus.
Area of Science:
- Endocrinology
- Molecular Biology
- Vascular Biology
Background:
- Plasma coupling factor 6 (CF6) is a novel vasoactive peptide.
- Elevated CF6 levels are observed in patients with diabetes mellitus.
- The underlying mechanism for CF6 elevation in diabetes remains unclear.
Purpose of the Study:
- To investigate the mechanism of CF6 protein release in human umbilical vein endothelial cells (HUVECs).
- To determine the effect of high glucose on CF6 expression and secretion.
- To elucidate the signaling pathways involved in high glucose-induced CF6 release.
Main Methods:
- HUVECs were incubated with varying concentrations and durations of high glucose.
- Osmolarity effects were controlled for.
- Protein kinase C (PKC) and p38 mitogen-activated protein kinase (MAPK) inhibitors were used.
- Insulin treatment was applied to assess its effect on CF6 production.
Main Results:
- High glucose significantly enhanced CF6 expression and secretion in HUVECs in a time- and concentration-dependent manner.
- This effect was independent of increased osmolarity.
- Inhibition of PKC and p38 MAPK suppressed high glucose-mediated CF6 release by -45% and -30%, respectively.
- Insulin treatment antagonized high glucose-induced CF6 production.
Conclusions:
- High glucose increases CF6 expression and secretion in endothelial cells.
- The mechanism involves the activation of PKC and p38 MAPK signaling pathways.
- These findings suggest a potential role for CF6 in the pathophysiology of diabetes mellitus.
Abstract:
As a novel vasoactive peptide, plasma coupling factor 6 (CF6) was shown to be elevated in patients with diabetes mellitus, yet the mechanism involved is unknown. We studied CF6 protein release and its potential mechanism in human umbilical vein endothelial cells (HUVECs) incubated with high glucose levels. High glucose level enhanced CF6 expression and peptide secretion in HUVECs in a time- and concentration-dependent manner, which was independent of increased osmolarity. PKC or p38 MAPK inhibition significantly suppressed high glucose-mediated CF6 release in HUVECs, and the inhibition rate was -45% and -30%, respectively. Also, high glucose-induced CF6 production was antagonized by insulin treatment. Hence, high glucose increases the expression and secretion of CF6 in endothelial cells and appears to be mediated by PKC and p38 MAPK activity.
Related Concept Videos
Insulin Secretory Vesicles
Regulation of Angiogenesis and Blood Supply
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Cell Specific Gene Expression
Glucose Absorption Into the Small Intestine